Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04092673
Title Study of eFT226 in Subjects With Selected Advanced Solid Tumor Malignancies (Zotatifin)
Acronym Zotatifin
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Effector Therapeutics
Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST